EMCDDA Home
  • EN

Table TDI-21. Gender ratio by primary drug of clients entering treatment, 2011 or most recent year available

Part (i) New outpatient clients, ratio of males to females by country and primary drug

CountryOpioidsCocaineStimulantsHypnotics and sedativesHallucinogensVolatile substancesCannabisOther drugsGender and drug known
Belgium4.74.12.11.01.05.06.31.91755
Bulgaria4.5:0.5:::1.3:206
Czech Republic12.4:1.80.2:0.02.83.0862
Denmark1.74.11.91.33.0:3.41.41417
Germany3.35.92.30.85.41.26.33.517325
Estonia3.0:1.0::4.02.8:163
Ireland22.26.32.51.4:1.45.12.32243
Greece7.85.91.81.20.0:5.60.01916
Spain24.75.94.01.76.125.56.12.026699
France3.03.04.20.74.02.26.93.09625
Italy33.98.71.70.23.00.011.55.822899
Cyprus12.323.0:2.5::10.5:387
Latvia3.8:2.50.93.01.613.63.2369
Lithuania44.8:4.00.8:1.0:3.9251
Luxembourg:::::::::
Hungary53.75.13.10.32.0:9.84.42619
Malta3.27.73.0:::3.2:183
Netherlands3.24.63.01.43.52.53.20.76813
Austria2.59.14.21.13.0:4.82.31150
Poland63.65.05.90.40.0:6.43.0200
Portugal75.74.41.30.7::7.27.41800
Romania3.8:::::9.06.7473
Slovenia3.11.70.01.0::2.50.0207
Slovakia82.9:2.71.0:8.012.3:326
Finland2.0:0.92.0:0.03.30.0186
Sweden2:::::::::
United Kingdom92.64.21.71.42.11.43.41.643066
Croatia104.04.44.12.3::6.5:986
Turkey:::::::::
Norway:::::::::
Total3.35.72.21.22.61.95.22.6 4.0
Total base422333014080323552493421575941661144126
 

Notes:

Empty cells correspond to instances where no female case has been reported. In such instances, the number of male cases also tends to be small or zero, but if the number of male clients exceeds 5 units, then a specific note is presented. Ratios equal to zero correspond to instances where no male cases have been reported while female cases have been reported. In such instances, the number of female cases tends also to be small, but if the number of female client exceeds 5 units, then a specific note is presented.

1 - 6 Cocaine Male clients reported.

2 - Data are from 2010.

3 - In 2011 around 27% of all clients and 32% of new clients were registered as not known / missing for the primary drug category. Caution should be made when comparing data over time.

4 - 9 Cannabis Male clients reported.

5 - 14 Volatile and Inhalants Male clients reported.

6 - Data are from 2010. Data presented in the table come from TDI pilot project. Caution should be made when interpreting the data

7 - In 2010 came into implementation a new national information system implying methodological changes particularly in the registration criteria. Caution should be made when comparing 2010 data with previous years. Other substances includes patients with alcohol and tobacco.

8 - 6 Cocaine Male clients reported.

9 - Data are from 1st of April 2010 to 31st March 2011.

10 - 14 Male clients reported for Other Drugs.

For more information relative to the treatment centre type, please see Table TDI-7.

See also 'General notes for interpreting data' on the Explanatory notes and help page.

Source:

Reitox national reports 2012 — TDI — outpatient treatment centres.

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Page last updated: Friday, 26 April 2013